DrugDashboards

Quetiapine

Quetiapine · QUETIAPINE FUMARATE 300 mg/1 · Tablet, Film Coated, Extended Release · Oral · Major Pharmaceuticals

NDC 00904-6804-61 · 100 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →

The short version

10 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.2764 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.2764per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicaid generic ceiling (FUL)$0.5127per TABweighted avg manufacturer price $0.2930 · Aug 1, 2026185% of what pharmacies pay — higher than 86% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Jul 2019Sep 2026$0.2764
87 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$8.29
#90 count
$24.88

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for quetiapine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA204203
TE code
AB
Approval date
May 17, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedFeb 27, 2020
    The Harvard Drug Group — Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.
  • Class III · TerminatedFeb 27, 2020
    The Harvard Drug Group — Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.
  • Class III · TerminatedFeb 27, 2020
    The Harvard Drug Group — Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.
  • Class III · TerminatedFeb 27, 2020
    The Harvard Drug Group — Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.

Manufacturers of Quetiapine (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
ACI Healthcare USA, Inc.QUETIAPINE FUMARATE 50 mg/1Jul 15, 2026Sep 2, 2026
ACI Healthcare USA, Inc.QUETIAPINE FUMARATE 200 mg/1Jul 15, 2026Sep 2, 2026
ACI Healthcare USA, Inc.QUETIAPINE FUMARATE 150 mg/1Jul 15, 2026Sep 2, 2026
ACI Healthcare USA, Inc.QUETIAPINE FUMARATE 300 mg/1Jul 15, 2026Sep 2, 2026
ACI Healthcare USA, Inc.QUETIAPINE FUMARATE 400 mg/1Jul 15, 2026Sep 2, 2026
AlignScience Pharma Inc.QUETIAPINE FUMARATE 150 mg/1Jul 15, 2026Sep 2, 2026
AlignScience Pharma Inc.QUETIAPINE FUMARATE 200 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedQUETIAPINE FUMARATE 300 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedQUETIAPINE FUMARATE 150 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedQUETIAPINE FUMARATE 200 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedQUETIAPINE FUMARATE 400 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedQUETIAPINE FUMARATE 50 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.QUETIAPINE FUMARATE 300 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.QUETIAPINE FUMARATE 200 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.QUETIAPINE FUMARATE 50 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.QUETIAPINE FUMARATE 150 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.QUETIAPINE FUMARATE 400 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.QUETIAPINE FUMARATE 200 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.QUETIAPINE FUMARATE 300 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.QUETIAPINE FUMARATE 150 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.QUETIAPINE FUMARATE 400 mg/1Jul 15, 2026Sep 2, 2026
Lupin Pharmaceuticals, Inc.QUETIAPINE FUMARATE 50 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsQUETIAPINE FUMARATE 200 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsQUETIAPINE FUMARATE 400 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsQUETIAPINE FUMARATE 300 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsQUETIAPINE FUMARATE 150 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsQUETIAPINE FUMARATE 50 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals, Inc.QUETIAPINE FUMARATE 50 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.QUETIAPINE FUMARATE 150 mg/1Jul 15, 2026Sep 2, 2026
ScieGen Pharmaceuticals, IncQUETIAPINE FUMARATE 150 mg/1Jul 15, 2026Sep 2, 2026
ScieGen Pharmaceuticals, IncQUETIAPINE FUMARATE 50 mg/1Jul 15, 2026Sep 2, 2026
ScieGen Pharmaceuticals, IncQUETIAPINE FUMARATE 400 mg/1Jul 15, 2026Sep 2, 2026
ScieGen Pharmaceuticals, IncQUETIAPINE FUMARATE 200 mg/1Jul 15, 2026Sep 2, 2026
ScieGen Pharmaceuticals, IncQUETIAPINE FUMARATE 300 mg/1Jul 15, 2026Sep 2, 2026
St. Mary's Medical Park PharmacyQUETIAPINE FUMARATE 200 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Quetiapine — NDC 00904-6804-61," retrieved September 3, 2026, https://drugdashboards.com/drug/00904680461.

Free to cite with attribution — see how the data is put together.